Navigation Links
Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments
Date:10/6/2011

type of cancer and predict its severity.

"The problem is, anytime you have a human being in the equation, there's always a question of variability," he said. "What one observer calls aggressive, another may not."

Madabhushi noted that until less than a decade ago, oncologists would be cautious and prescribe both hormone therapy and chemotherapy because the severity was often hard to determine. In 2004, California-based Genomic Health introduced a test that examined gene expression. That test accurately pegged ER+ breast cancers that fell at the low and high ends of the severity scale. Women who scored low could be treated confidently with hormonal therapy alone and forgo chemotherapy.

While the test, known as Oncotype DX, became an important planning resource for oncologists and patients, it remains expensive upwards of $4,000. It also takes two weeks to produce results, which for severe cancers represents a loss of valuable treatment time.

"In 2007, an oncologist at The Cancer Institute of New Jersey, Shridar Ganesan, saw our work on prostate cancer imaging and asked if my lab could apply it to ER-positive breast cancers," said Madabhushi, who is also a member of The Cancer Institute of New Jersey. "So we applied these techniques and started to get very exciting results. We found that our image-based risk score, which we dubbed 'Ibris,' was in agreement with the Oncotype DX score almost 90 percent of the time."

Work funded by the NIH grant, made through the agency's National Institute for Biomedical Imaging and Bioengineering, will establish how well Ibris scores predict long-term patient outcomes. If successful, an Ibris test could deliver results to patients almost immediately and cut costs to patients and their insurers.

The benefits could be even more dramatic in developing countries, claims Madabhushi, where the Oncotype DX cost is prohibitive and sending samples to California can add weeks to the testing
'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
2. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
3. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
4. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
5. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
6. Iowa State chemist synthesizes carbohydrates, launches startup company
7. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
8. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
9. Two is not company -- as far as fish are concerned
10. GATC Biotech AG is investing more than 5 million euros in its Constance site to double the companys floor space
11. Company Granted Patent on Apparatus, Systems, and Methods for Gathering and Processing Wireless Biometric and Biomechanical Data
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments
(Date:9/23/2014)... proteins to survive in the icy Southern Ocean ... by the National Science Foundation (NSF) report: The ... resist melting even when temperatures warm. , ... consequence of the evolution of antifreeze proteins in ... student Paul Cziko, who led the research with ...
(Date:9/23/2014)... the body forms new tissues during the healing ... each other. For years, scientists believed this communication ... Carnegie Mellon University and the University of Pittsburgh ... is equally if not more crucial. The ... Proceedings of the National Academy of Sciences ...
(Date:9/23/2014)... have scoured cow rumens and termite guts for microbes ... the production of next-generation biofuels, but some of the ... lower intestine, researchers report. , Their study , ... of Sciences , is the first to use biochemical ... human gut can digest fiber, breaking it down into ...
Breaking Biology News(10 mins):Antifreeze proteins in Antarctic fish prevent both freezing and melting 2Antifreeze proteins in Antarctic fish prevent both freezing and melting 3The mechanics of tissue growth 2Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... Liver transplant patients with hepatitis C virus (HCV) ... the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination ... virus in vitro. , The results of ... of Liver Transplantation, the official journal of the ...
... infants born with HIV infection may be most effective ... according to a study published in the April 1 ... online. , Uncertainty over when to start antiretroviral treatment ... around balancing the benefits of preventing disease progression and ...
... in which single strands of synthetic DNA are used ... been developed by researchers with the Lawrence Berkeley National ... Berkeley. This technique holds promise for a wide ... of artificial tissues and the design of neural networks. ...
Cached Biology News:Cyclosporine inhibits hepatitis C virus in vitro 2New study shows benefit of early therapy in HIV-infected infants 2Berkeley researchers lay groundwork for cell version of DNA chip 2Berkeley researchers lay groundwork for cell version of DNA chip 3Berkeley researchers lay groundwork for cell version of DNA chip 4
(Date:9/23/2014)... 23, 2014 News Facts ... devoted to genome-based research for human health and ... is taking a bite out of oral cancer with its ... India with the help of state-of-the-art ... Networks (DDN). , To fuel its cutting-edge cancer research, ...
(Date:9/23/2014)... , September 23, 2014 ... System Transfer     Devices  (CSTD) for ... with Taiwanese distributor MedFront Medical Technology Corporation.  Equashield,s leading CSTD ... Taiwan , China ... company continues to expand globally, and throughout the ...
(Date:9/23/2014)... The Minnesota High Tech Association (MHTA) ... modems , platforms and application-specific remote monitoring systems, ... the 2014 Tekne Awards. The awards ceremony ... Center on Thursday, November 13th. The Tekne Awards ... superior technology innovation and leadership. , The ...
(Date:9/22/2014)... , September 22, 2014 ... announced the addition of the "Global Biotechnology ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology ... added to a system to detect and examine ... are generally used in laboratories to prepare, collect, ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based biotechnology ... an,operational update for the quarter ended June 30, 2007. ... 2007 The Company recorded a net loss of ... to net income of $197,750 for the same period,in ...
... Transgenomic, Inc. (the,"Company") (OTC Bulletin Board: TBIO) today ... The Company,s financial results are,presented in the tables that ... a net profit of $0.2 million or $0.00 per ... a net loss of $0.4 million or,$0.01 per share ...
... Martek Biosciences,Corporation announced that it intends to release ... September 5, 2007, at approximately 4:00 p.m.,Eastern Daylight Time ... hold a conference call to discuss the results of ... is expected to be approximately one,hour in duration. The ...
Cached Biology Technology:GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 6Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Martek to Announce Third Quarter 2007 Results on September 5, 2007 2